Reply to: "Renal impairment and anemia during triple therapy"
J Hepatol
.
2014 May;60(5):1100-1.
doi: 10.1016/j.jhep.2014.01.007.
Epub 2014 Jan 18.
Authors
Manuel Romero-Gómez
1
,
Marina Berenguer
2
,
Esther Molina
3
,
Jose-Luis Calleja
4
Affiliations
1
UCM Digestive Diseases and CIBERehd, Hospital Universitario de Valme, Universidad de Sevilla, Sevilla, Spain.
2
Liver Transplant Unit, Hospital La Fe, Universidad de Valencia, and CIBERehd, Valencia, Spain. Electronic address:
[email protected]
.
3
Liver Transplant Unit, Complejo Hospitalario Universitario de Santiago de Compostela, Coruña, Spain.
4
Gastroenterology and Hepatology Service, Hospital Universitario de Puerta de Hierro-Majadahonda, Universidad Autónoma de Madrid, Madrid, Spain.
PMID:
24445218
DOI:
10.1016/j.jhep.2014.01.007
No abstract available
Publication types
Letter
Comment
MeSH terms
Anemia / therapy*
Hepatitis C, Chronic / drug therapy*
Humans